Education
About Us
Working with TipRanks
Follow Us
Inhibrx Biosciences, Inc. (INBX)
:INBX
Inhibrx Biosciences Inc (INBX) Ownership Overview
27.36% Insiders
6.41% Mutual Funds
43.46% Other Institutional Investors
8.48% ETFs
14.28% Public Companies and Individual Investors
The ownership structure of Inhibrx Biosciences Inc (INBX) stock is a mix of institutional, retail, and individual investors. Approximately 58.35% of the company’s stock is owned by Institutional Investors, 27.36% is owned by Insiders, and 14.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 22, 2024 | Jon Faiz Kayyem Director | xxxxxxxxxxxxx | $1523060 |
| Oct 07, 2024 | Kristiina Vuori Director | xxxxxxxxxxxxx | $100005 |
| Sep 16, 2024 | Mark Lappe Ceo,director | xxxxxxxxxxxxx | $629117 |
| Sep 12, 2024 | Kristiina Vuori Director | xxxxxxxxxxxxx | $99992 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,787,705 | Institution | 12.35% | 23,937,370 | |
| 1,157,926 | Insider | 8.00% | 15,504,629 | |
| 1,149,046 | Insider | 7.94% | 15,385,726 | |
| 1,064,026 | Institution | 7.35% | 14,247,308 | |
| 925,413 | Insider | 6.39% | 12,391,280 | |
| 577,477 | Institution | 3.99% | 7,732,417 | |
| 529,457 | Institution | 3.66% | 7,089,429 | |
| 473,888 | Insider | 3.27% | 6,345,360 | |
| 436,564 | Institution | 3.02% | 5,845,592 | |
| 224,564 | Insider | 1.55% | 3,006,912 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 436,564 | Institution | 3.02% | 5,845,592 | |
| 126,731 | Institution | 0.88% | 1,696,928 | |
| 91,365 | Institution | 0.63% | 1,223,377 | |
| 81,746 | Institution | 0.56% | 1,094,579 | |
| 64,683 | Institution | 0.45% | 866,105 | |
| 32,657 | Institution | 0.23% | 437,277 | |
| 24,228 | Institution | 0.17% | 324,413 | |
| 20,366 | Institution | 0.14% | 272,701 | |
| 6,800 | Institution | 0.05% | 91,052 | |
| 6,746 | Institution | 0.05% | 90,329 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 337,352 | Institution | 2.33% | 5,195,221 | |
| 311,397 | Institution | 2.15% | 4,169,606 | |
| 175,317 | Institution | 1.21% | 2,699,882 | |
| 61,577 | Institution | 0.43% | 824,516 | |
| 55,965 | Institution | 0.39% | 749,371 | |
| 55,224 | Institution | 0.38% | 850,450 | |
| 47,585 | Institution | 0.33% | 637,163 | |
| 30,785 | Institution | 0.21% | 404,515 | |
| 26,637 | Institution | 0.18% | 356,669 | |
| 24,712 | Institution | 0.17% | 324,716 |
FAQ
Who Owns Inhibrx Biosciences, Inc. (INBX)?
According to the latest TipRanks data, approximately 43.46% of the company's stock is held by institutional investors, 27.36% is held by insiders, and 14.28% is held by retail investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.46% of Inhibrx Biosciences, Inc. (INBX) stock is held by institutional investors.
What percentage of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.28% of Inhibrx Biosciences, Inc. (INBX) stock is held by retail investors.
Who owns the most shares of Inhibrx Biosciences, Inc. (INBX)?
Andreas Halvorsen owns the most shares of Inhibrx Biosciences, Inc. (INBX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.